Marksans Pharma Limited has informed the Exchange regarding a press release dated March 10, 2023, titled "Marksans Pharma Limited announces US FDA approval for Famotidine Tablets USP, 10 mg and 20 mg.".
Marksans Pharma Limited has informed the Exchange regarding a press release dated March 10, 2023, titled "Marksans Pharma Limited announces US FDA approval for Famotidine Tablets USP, 10 mg and 20 mg.".